These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 6202447)

  • 1. Somatomedin/insulin-like growth factor tissue receptors.
    Nissley SP; Rechler MM
    Clin Endocrinol Metab; 1984 Mar; 13(1):43-67. PubMed ID: 6202447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of somatomedin/insulin-like growth factor receptors and correlation with biologic action in cultured neonatal rat astroglial cells.
    Han VK; Lauder JM; D'Ercole AJ
    J Neurosci; 1987 Feb; 7(2):501-11. PubMed ID: 2950212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nature and regulation of the receptors for insulin-like growth factors.
    Rechler MM; Nissley SP
    Annu Rev Physiol; 1985; 47():425-42. PubMed ID: 2986537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor II binding to the type I somatomedin receptor. Evidence for two high affinity binding sites.
    Casella SJ; Han VK; D'Ercole AJ; Svoboda ME; Van Wyk JJ
    J Biol Chem; 1986 Jul; 261(20):9268-73. PubMed ID: 3013881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor receptors in rat placental membranes.
    Pilistine SJ; Moses AC; Munro HN
    Endocrinology; 1984 Sep; 115(3):1060-5. PubMed ID: 6086283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct demonstration of rapid insulin-like growth factor II Receptor internalization and recycling in rat adipocytes. Insulin stimulates 125I-insulin-like growth factor II degradation by modulating the IGF-II receptor recycling process.
    Oka Y; Rozek LM; Czech MP
    J Biol Chem; 1985 Aug; 260(16):9435-42. PubMed ID: 2991246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a single cleavage in insulin-like growth factors I and II on binding to receptors, carrier proteins and antibodies.
    Jansen J; van Buul-Offers SC; Hoogerbrugge CM; Van Den Brande JL
    Biochem J; 1990 Mar; 266(2):513-20. PubMed ID: 2156497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The type II insulin-like growth factor receptor does not mediate increased DNA synthesis in H-35 hepatoma cells.
    Mottola C; Czech MP
    J Biol Chem; 1984 Oct; 259(20):12705-13. PubMed ID: 6092344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble 34K binding protein inhibits the binding of insulin-like growth factor I to its cell receptors in human secretory phase endometrium: evidence for autocrine/paracrine regulation of growth factor action.
    Rutanen EM; Pekonen F; Mäkinen T
    J Clin Endocrinol Metab; 1988 Jan; 66(1):173-80. PubMed ID: 2961785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity-labeled somatomedin-C receptors and binding proteins from the human fetus.
    Grizzard JD; D'Ercole AJ; Wilkins JR; Moats-Staats BM; Williams RW
    J Clin Endocrinol Metab; 1984 Mar; 58(3):535-43. PubMed ID: 6198334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells.
    Ritvos O; Ranta T; Jalkanen J; Suikkari AM; Voutilainen R; Bohn H; Rutanen EM
    Endocrinology; 1988 May; 122(5):2150-7. PubMed ID: 2452077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor receptors and binding protein in rat neuroblastoma cells.
    Sturm MA; Conover CA; Pham H; Rosenfeld RG
    Endocrinology; 1989 Jan; 124(1):388-96. PubMed ID: 2462492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor receptors.
    Nissley SP; Haskell JF; Sasaki N; De Vroede MA; Rechler MM
    J Cell Sci Suppl; 1985; 3():39-51. PubMed ID: 3011825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-I receptors in human glial tumors.
    Merrill MJ; Edwards NA
    J Clin Endocrinol Metab; 1990 Jul; 71(1):199-209. PubMed ID: 2164527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of insulin-like growth factors I and II and multiplication-stimulating activity with receptors and serum carrier proteins.
    Rechler MM; Zapf J; Nissley SP; Froesch ER; Moses AC; Podskalny JM; Schilling EE; Humbel RE
    Endocrinology; 1980 Nov; 107(5):1451-9. PubMed ID: 6159199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further characterization of human basic-somatomedin: comparison with insulin-like growth factors I and II.
    Bhaumick B; Goren HJ; Bala RM
    Horm Metab Res; 1981 Sep; 13(9):515-8. PubMed ID: 6271660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ontogeny and characterization of basic somatomedin receptors in rat placenta.
    Bhaumick B; Bala RM
    Endocrinology; 1985 Feb; 116(2):492-8. PubMed ID: 2981662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of insulinlike growth factor I binding to human fibroblast monolayer cultures by insulinlike growth factor carrier proteins released to the incubation media.
    De Vroede MA; Tseng LY; Katsoyannis PG; Nissley SP; Rechler MM
    J Clin Invest; 1986 Feb; 77(2):602-13. PubMed ID: 2418066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different insulin-like growth factor binding species in human placenta and decidua.
    Pekonen F; Suikkari AM; Mäkinen T; Rutanen EM
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1250-7. PubMed ID: 2461387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of type I and type II somatomedin receptors on bovine growth plate chondrocytes.
    Trippel SB; Chernausek SD; Van Wyk JJ; Moses AC; Mankin HJ
    J Orthop Res; 1988; 6(6):817-26. PubMed ID: 2971791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.